The European Union-wide data shows that in 2015, antibiotic resistance continued to increase for most bacteria and antibiotics under surveillance. The average percentage of carbapenem resistance in Klebsiella pneumoniae increased from 6.2 percent in 2012 to 8.1 percent in 2015, and healthcare organizations reported a combined resistance to carbapenems and polymyxins as well.
Additionally, resistance to common antibiotics among patients infected with Escherichia coli, a frequent cause of bloodstream infections and community-and healthcare-associated urinary tract infections, is increasing.
“Antibiotic resistance is one of the most pressing public health issues of our time. If we don’t tackle it, we can go back to a time when even the simplest medical operations were not possible, and organ transplants, cancer chemotherapy or intensive care even less so,” said Vytenis Andriukaitis, European commissioner for health and food safety, in a statement. “The European Commission will launch a new action plan next year so that we can, together with our partners in the EU Member States and internationally, continue to ensure that the prevention and control of antibiotic resistance is strengthened within a one-health approach.”
More articles on healthcare quality:
Higher staffing proportion of professional nurses linked to better quality
CMS overall star ratings ‘will do more harm than good to patients,’ 2 experts say
Hospital quality measures need work: Mass General experts weigh in
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.